• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向性小干扰RNA递送可减少脊髓损伤后一氧化氮介导的细胞死亡。

Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury.

作者信息

Gao Wen, Li Jianming

机构信息

Department of Basic Medical Sciences, Center for Paralysis Research, College of Veterinary Medicine, Purdue University, 408 S. University St., West Lafayette, IN, 47907, USA.

出版信息

J Nanobiotechnology. 2017 May 8;15(1):38. doi: 10.1186/s12951-017-0272-7.

DOI:10.1186/s12951-017-0272-7
PMID:28482882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5422875/
Abstract

BACKGROUND

Traumatic spinal cord injury (SCI) includes the primary insult as well as a sequela of biochemical and cellular cascades that amplifies the initial injury. This degenerative process, known as secondary injury, is often mediated by both reactive oxygen and nitrogen species released from damaged cells. Previous data suggests that dysregulated production of nitric oxide via inducible nitric oxide synthase (iNOS) is detrimental to spinal cord recovery. M1 macrophages have been implicated to overexpress iNOS post-SCI. In this work, we propose to inhibit iNOS expression through small interfering RNA (siRNA) complexed chitosan nanoparticles (NPs) that primarily target M1 macrophages.

METHODS

siRNA conjugated chitosan complexes were fabricated with and without an antibody (Ab) targeting moiety and screened for efficiency to reduce iNOS expression in vitro. Best formulations were subsequently applied in vivo following acute SCI in a rodent model. iNOS expression as well as Bax and Bcl-2 biomarkers were used to assess cell apoptosis within the lesion at 24 h post-injury.

RESULTS

Ab-siRNA conjugated chitosan NPs significantly reduced iNOS expression in vitro in M1 polarized macrophages. Results show high transfection efficiency with low cytotoxicity. Subsequent application of NPs in vivo after SCI demonstrated both a reduction in iNOS expression and cellular apoptosis.

CONCLUSION

Proof of concept indicates that siRNA conjugated chitosan NPs can downregulate iNOS production and inhibit apoptosis following SCI. Our proposed gene silencing method putatively targets M1 macrophages as a means to attenuate secondary injury.

摘要

背景

创伤性脊髓损伤(SCI)包括原发性损伤以及一系列生化和细胞级联反应的后遗症,这些反应会加剧初始损伤。这种退行性过程,即继发性损伤,通常由受损细胞释放的活性氧和氮物质介导。先前的数据表明,通过诱导型一氧化氮合酶(iNOS)产生的一氧化氮失调对脊髓恢复有害。M1巨噬细胞被认为在脊髓损伤后会过度表达iNOS。在这项研究中,我们提议通过与壳聚糖纳米颗粒(NPs)复合的小干扰RNA(siRNA)来抑制iNOS的表达,该纳米颗粒主要靶向M1巨噬细胞。

方法

制备带有和不带有抗体(Ab)靶向部分的siRNA共轭壳聚糖复合物,并在体外筛选其降低iNOS表达的效率。随后将最佳制剂应用于啮齿动物急性脊髓损伤后的体内实验。在损伤后24小时,使用iNOS表达以及Bax和Bcl-2生物标志物来评估损伤部位的细胞凋亡。

结果

Ab-siRNA共轭壳聚糖纳米颗粒在体外显著降低了M1极化巨噬细胞中的iNOS表达。结果显示转染效率高且细胞毒性低。脊髓损伤后在体内随后应用纳米颗粒表明iNOS表达和细胞凋亡均减少。

结论

概念验证表明,siRNA共轭壳聚糖纳米颗粒可以下调脊髓损伤后iNOS的产生并抑制细胞凋亡。我们提出的基因沉默方法可能以M1巨噬细胞为靶点,作为减轻继发性损伤的一种手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/0aa3305e65c5/12951_2017_272_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/08da02ba7b2d/12951_2017_272_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/fbf39c8337bd/12951_2017_272_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/e41163413714/12951_2017_272_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/980779898542/12951_2017_272_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/0aa3305e65c5/12951_2017_272_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/08da02ba7b2d/12951_2017_272_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/fbf39c8337bd/12951_2017_272_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/e41163413714/12951_2017_272_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/980779898542/12951_2017_272_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81c8/5422875/0aa3305e65c5/12951_2017_272_Fig5_HTML.jpg

相似文献

1
Targeted siRNA delivery reduces nitric oxide mediated cell death after spinal cord injury.靶向性小干扰RNA递送可减少脊髓损伤后一氧化氮介导的细胞死亡。
J Nanobiotechnology. 2017 May 8;15(1):38. doi: 10.1186/s12951-017-0272-7.
2
ERK1/2 and p38 mitogen-activated protein kinase mediate iNOS-induced spinal neuron degeneration after acute traumatic spinal cord injury.细胞外信号调节激酶1/2(ERK1/2)和p38丝裂原活化蛋白激酶介导急性创伤性脊髓损伤后诱导型一氧化氮合酶(iNOS)引起的脊髓神经元变性。
Life Sci. 2006 Oct 12;79(20):1895-905. doi: 10.1016/j.lfs.2006.06.023. Epub 2006 Jun 21.
3
Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury.一氧化氮通过巨噬细胞诱导型一氧化氮合酶在创伤性脊髓损伤后诱导细胞凋亡。
Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):114-22. doi: 10.1016/s0169-328x(00)00253-9.
4
Acute molecular perturbation of inducible nitric oxide synthase with an antisense approach enhances neuronal preservation and functional recovery after contusive spinal cord injury.采用反义技术急性分子干扰诱导型一氧化氮合酶可增强创伤性脊髓损伤后的神经元保护和功能恢复。
J Neurotrauma. 2012 Aug 10;29(12):2244-9. doi: 10.1089/neu.2012.2371.
5
Hyperbaric oxygen therapy provides neuroprotection following spinal cord injury in a rat model.在大鼠模型中,高压氧疗法可在脊髓损伤后提供神经保护作用。
Int J Clin Exp Pathol. 2013 Jun 15;6(7):1337-42. Print 2013.
6
Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice.纳米颗粒递送的 IRF5 siRNA 促进 M1 向 M2 转化,减少脱髓鞘和神经丝丢失,并促进小鼠脊髓损伤后的功能恢复。
Inflammation. 2016 Oct;39(5):1704-17. doi: 10.1007/s10753-016-0405-4.
7
Identifying the Long-Term Role of Inducible Nitric Oxide Synthase after Contusive Spinal Cord Injury Using a Transgenic Mouse Model.使用转基因小鼠模型确定诱导型一氧化氮合酶在脊髓挫伤性损伤后的长期作用
Int J Mol Sci. 2017 Jan 25;18(2):245. doi: 10.3390/ijms18020245.
8
[Necrostatin-1 promotes locomotor recovery after spinal cord injury through inhibiting apoptosis and M1 polarization of microglia/macrophage in mice].[坏死抑制因子-1通过抑制小鼠脊髓损伤后小胶质细胞/巨噬细胞的凋亡和M1极化促进运动功能恢复]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021 Sep;37(9):775-780.
9
[Effect of M2-like macrophage/microglia-derived mitochondria transplantation in treatment of mouse spinal cord injury].[M2样巨噬细胞/小胶质细胞源性线粒体移植对小鼠脊髓损伤的治疗作用]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Jun 15;36(6):751-759. doi: 10.7507/1002-1892.202201040.
10
A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.乳糖神经酰胺在调节脂多糖/γ-干扰素介导的诱导型一氧化氮合酶基因表达中的新作用:对神经炎症性疾病的影响。
J Neurosci. 2004 Jun 30;24(26):5942-54. doi: 10.1523/JNEUROSCI.1271-04.2004.

引用本文的文献

1
Advancements in Antioxidant-Based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches.基于抗氧化剂的脊髓损伤治疗进展:策略与联合方法的批判性综述
Antioxidants (Basel). 2024 Dec 26;14(1):17. doi: 10.3390/antiox14010017.
2
From apoptosis to pyroptosis: A two-decade analysis of spinal cord injury systematic review.从细胞凋亡到细胞焦亡:脊髓损伤系统综述二十年分析。
Medicine (Baltimore). 2024 Oct 4;103(40):e39951. doi: 10.1097/MD.0000000000039951.
3
RNA Interference Unleashed: Current Perspective of Small Interfering RNA (siRNA) Therapeutics in the Treatment of Neuropathic Pain.

本文引用的文献

1
Macrophage polarization: a key event in the secondary phase of acute spinal cord injury.巨噬细胞极化:急性脊髓损伤二期的关键事件。
J Cell Mol Med. 2017 May;21(5):941-954. doi: 10.1111/jcmm.13034. Epub 2016 Dec 13.
2
Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.纳米颗粒的表面修饰使它们能够有选择地逃避不同巨噬细胞表型的吞噬清除。
Sci Rep. 2016 May 19;6:26269. doi: 10.1038/srep26269.
3
Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides.
RNA干扰的释放:小干扰RNA(siRNA)疗法治疗神经性疼痛的当前视角
ACS Pharmacol Transl Sci. 2024 Sep 23;7(10):2951-2970. doi: 10.1021/acsptsci.4c00329. eCollection 2024 Oct 11.
4
Recent advances in the application of gasotransmitters in spinal cord injury.气体递质在脊髓损伤应用中的最新进展。
J Nanobiotechnology. 2024 May 23;22(1):277. doi: 10.1186/s12951-024-02523-3.
5
Neurotrauma-From Injury to Repair: Clinical Perspectives, Cellular Mechanisms and Promoting Regeneration of the Injured Brain and Spinal Cord.神经创伤——从损伤到修复:临床视角、细胞机制与促进损伤脑和脊髓的再生
Biomedicines. 2024 Mar 13;12(3):643. doi: 10.3390/biomedicines12030643.
6
α-Gal Nanoparticles in CNS Trauma: II. Immunomodulation Following Spinal Cord Injury (SCI) Improves Functional Outcomes.中枢神经系统创伤中的α-半乳糖纳米颗粒:II. 脊髓损伤(SCI)后的免疫调节改善功能结局。
Tissue Eng Regen Med. 2024 Apr;21(3):437-453. doi: 10.1007/s13770-023-00616-y. Epub 2024 Feb 3.
7
α-Gal Nanoparticles in CNS Trauma: I. In Vitro Activation of Microglia Towards a Pro-Healing State.中枢神经系统创伤中的α-半乳糖纳米颗粒:I. 小胶质细胞向促愈合状态的体外激活
Tissue Eng Regen Med. 2024 Apr;21(3):409-419. doi: 10.1007/s13770-023-00613-1. Epub 2023 Dec 15.
8
CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.中枢神经系统递药:超越血脑屏障和迈向特定细胞靶向。
Pharm Res. 2023 Jan;40(1):77-105. doi: 10.1007/s11095-022-03433-5. Epub 2022 Nov 15.
9
Inflammation: A Target for Treatment in Spinal Cord Injury.炎症:脊髓损伤治疗的新靶点
Cells. 2022 Aug 29;11(17):2692. doi: 10.3390/cells11172692.
10
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases.siRNA 疗法:神经退行性疾病的未来希望。
Curr Neuropharmacol. 2021;19(11):1896-1911. doi: 10.2174/1570159X19666210402104054.
壳聚糖和壳寡糖的表征及生物活性研究进展。
Food Chem. 2016 Jan 1;190:1174-1181. doi: 10.1016/j.foodchem.2015.06.076. Epub 2015 Jun 23.
4
Recent advances in nanoparticle-mediated siRNA delivery.纳米颗粒介导的小干扰RNA递送的最新进展
Annu Rev Biomed Eng. 2014 Jul 11;16:347-70. doi: 10.1146/annurev-bioeng-071813-105119. Epub 2014 Jun 2.
5
Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death.脊髓损伤后小胶质细胞和外周巨噬细胞吞噬反应的差异及其对细胞死亡的影响。
J Neurosci. 2014 Apr 30;34(18):6316-22. doi: 10.1523/JNEUROSCI.4912-13.2014.
6
RNAi Therapeutics in Autoimmune Disease.RNAi 治疗自身免疫性疾病。
Pharmaceuticals (Basel). 2013 Mar 5;6(3):287-94. doi: 10.3390/ph6030287.
7
Modulation of macrophage phenotype by cell shape.细胞形状对巨噬细胞表型的调节。
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8. doi: 10.1073/pnas.1308887110. Epub 2013 Oct 7.
8
Chitosan-based siRNA delivery systems.基于壳聚糖的 siRNA 递送系统。
J Control Release. 2013 Nov 28;172(1):207-218. doi: 10.1016/j.jconrel.2013.08.005. Epub 2013 Aug 18.
9
A review of the current status of siRNA nanomedicines in the treatment of cancer.一种用于癌症治疗的 siRNA 纳米药物的现状综述。
Biomaterials. 2013 Sep;34(27):6429-43. doi: 10.1016/j.biomaterials.2013.04.060. Epub 2013 May 30.
10
Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation.壳聚糖促进抗炎型巨噬细胞极化和促炎型树突状细胞的刺激。
Eur Cell Mater. 2012 Jul 24;24:136-52; discussion 152-3. doi: 10.22203/ecm.v024a10.